Reactive oxygen species, apoptosis, antimicrobial peptides and human inflammatory diseases

Pharmaceuticals

Volumn 8, Issue 2, 2015, Pages 151-175

  Oyinloye, Babatunji Emmanuel ^a,b   Adenowo, Abiola Fatimah ^a   Kappo, Abidemi Paul ^a  

^a UNIVERSITY OF ZULULAND   (South Africa)

^b AFE BABALOLA UNIVERSITY   (Nigeria)

Author keywords

Antimicrobial peptides; Apoptosis; Inflammation; Mitochondrial damage; Nuclear factor kappa B; Reactive oxygen species

Indexed keywords

ABAECIN; ACATHELICIDIN; ALPHA DEFENSIN; BACTENECIN; BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; CATHELICIDIN; CECROPIN; CECROPIN A; CECROPIN B; HYMENOPTAECIN; INDOLICIDIN; LIGATOXIN B; MAGAININ; MAGAININ A; MAXIMIN 1; MAXIMIN 2; MAXIMIN 3; MAXIMIN 4; MAXIMIN 5; MELITTIN; PLEUROCIDIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEGRIN; REACTIVE OXYGEN METABOLITE; THIONIN PEPTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; BLADDER CANCER; CYSTIC FIBROSIS; CYTOTOXICITY; DRUG ACTIVITY; DRUG CLASSIFICATION; DRUG DESIGN; DRUG EFFICACY; DRUG INDICATION; DRUG POTENCY; HELICOBACTER INFECTION; HUMAN; HUMAN INFLAMMATORY DISEASE; IMMUNE RESPONSE; INFLAMMATORY DISEASE; NONHUMAN; PROKARYOTE; REVIEW; WOUND HEALING;

EID: 84930211022     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph8020151     Document Type: Review

References (115)

1. Marchetti, M.A.; Weinberger, M.; Murakami, Y.; Burhans, W.C.; Huberman, J.A. Production of reactive oxygen species in response to replication stress and inappropriate mitosis in fission yeast. J. Cell. Sci. 2006, 119, 124-131.
2. Gonzalez, C.; Sanz-Alfayate, G.; Agapito, M.T.; Gomez-Niño, A.; Rocher, A.; Obeso, A. Significance of ROS in oxygen sensing in cell systems with sensitivity to physiological hypoxia. Respir. Physiol. Neurobiol. 2002, 132, 17-41.
3. Lee, J.; Koo, N.; Min, D.B. Reactive oxygen species, aging, and antioxidative nutraceuticals. Comp. Rev. Food Sci. Food Safety 2004, 3, 21-33.
4. Lobo, V.; Patil, A.; Phatak, A.; Chandra, N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn. Rev. 2010, 4, 118-126.
5. Dickinson, B.C.; Chang, C.J. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat. Chem. Biol. 2011, 7, 504-511.
6. Massaad, C.A. Neuronal and vascular oxidative stress in Alzheimer's disease. Curr. Neuropharmacol. 2011, 9, 662-673.
7. Wang, G. Human antimicrobial peptides and proteins. Pharmaceuticals 2014, 7, 545-594.
8. Heap, G.A.; van Heel, D.A. The genetics of chronic inflammatory diseases. Hum. Mol. Genet. 2009, 18, R101-R106.
9. Kirkham, P. Oxidative stress and macrophage function: A failure to resolve the inflammatory response. Biochem. Soc. Trans. 2007, 35 Pt 2, 284-287.
10. Finkel, T. Signal transduction by reactive oxygen species. J. Cell. Biol. 2011, 194, 7-15.
11. Hsieh, H.L.; Yang, C.M. Role of redox signaling in neuroinflammation and neurodegenerative diseases. Biomed. Res. Int. 2013, 2013, 484-613.
12. Schneeberger, K.; Czirják, G.A.; Voigt, C.C. Inflammatory challenge increases measures of oxidative stress in a free-ranging, long-lived mammal. J. Exp. Biol. 2013, 216, 4514-4519.
13. Muñoz, A.; Costa, M. Nutritionally mediated oxidative stress and inflammation. Oxid. Med. Cell. Longev. 2013, 2013, 610-950.
14. Naik, E.; Dixit, V.M. Mitochondrial reactive oxygen species drive pro-inflammatory cytokine production. J. Exp. Med. 2011, 208, 417-420.
15. Li, X.; Fang, P.; Mai, J.; Choi, E.T.; Wang, H.; Yang, X.F. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J. Hematol. Oncol. 2013, 6, 19.
16. Wright, H.L.; Moots, R.J.; Bucknall, R.C.; Edwards, S.W. Neutrophil function in inflammation and inflammatory diseases. Rheumatology 2010, 49, 1618-1631.
17. Wong, R.S.Y. Apoptosis in cancer: From pathogenesis to treatment. J. Exp. Clin. Cancer Res. 2011, 30, 87.
18. McIlwain, D.R.; Berger, T.; Mak, T.W. Caspase functions in cell death and disease. Cold Spring Harb. Perspect. Biol. 2013, 5, a008656.
19. Oyinloye, B.; Adenowo, F.; Gxaba, N.; Kappo, A. The promise of antimicrobial peptides for treatment of human schistosomiasis. Curr. Drug Targets 2014, 15, 852-859.
20. Cho, J.; Lee, D.J. The antimicrobial peptide arenicin-1 promotes generation of reactive oxygen species and induction of apoptosis. Biochim. Biophys. Acta 2011, 1810, 1246-1251.
21. Hwang, B.; Hwang, J.S.; Lee, J.; Lee, D.G. The antimicrobial peptide, psacotheasin induces reactive oxygen species and triggers apoptosis in Candida albicans. Biochem. Biophys. Res. Commun. 2011, 405, 267-271.
22. Zeya, H.I.; Spitznagel, J.K. Antimicrobial specificity of leukocyte lysosomal cationic proteins. Science 1966, 154, 1049-1051.
23. Palffy, R.; Gardlik, R.; Behuliak, M.; Kadasi, L.; Turna, J.; Celec, P. On the physiology and pathophysiology of antimicrobial peptides. Mol. Med. 2009, 15, 1-2.
24. Peters, B.M.; Shirtliff, M.E.; Jabra-Rizk, M.A. Antimicrobial peptides: Primeval molecules or future drugs? PLoS Pathog. 2010, 6, e1001067.
25. Kamysz, W. Are antimicrobial peptides an alternative for conventional antibiotics? Nucl. Med. Rev. Cent. East. Eur. 2005, 8, 78-86.
26. Reddy, K.V.R.; Yedery, R.D.; Aranha, C. Antimicrobial peptides: Premises and promises. Int. J. Antimicrob. Agents 2004, 24, 536-547.
27. Broekaert, W.F.; Terras, F.R.; Cammue, B.P.; Osborn, R.W. Plant defensins: Novel antimicrobial peptides as components of the host defense system. Plant Physiol. 1995, 108, 1353-1358.
28. Sang, Y.; Blecha, F. Antimicrobial peptides and bacteriocins: Alternatives to traditional antibiotics. Anim. Health Res. Rev. 2008, 9, 227-235.
29. Hancock, R.E.; Sahl, H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006, 24, 1551-1557.
30. Pacor, S.; Giangaspero, A.; Bacac, M.; Sava, G.; Tossi, A. Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: Implications for systemic use. J. Antimicrob. Chemother. 2002, 50, 339-348.
31. Raj, P.A.; Dentino, A.R. Current status of defensins and their role in innate and adaptive immunity. FEMSMicrobiol. Lett. 2002, 206, 9-18.
32. Kougias, P.; Chai, H.; Lin, P.H.; Yao, Q.; Lumsden, A.B.; Chen, C. Defensins and cathelicidins: Neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis. J. Cell. Mol. Med. 2005, 9, 3-10.
33. Mendez-Samperio, P. Recent advances in the field of antimicrobial peptides in inflammatory diseases. Adv. Biomed. Res. 2013, 2, 50.
34. Chen, X.; Niyonsaba, F.; Ushio, H.; Hara, M.; Yokoi, H.; Matsumoto, K.; Saito, H.; Nagaoka, I.; Ikeda, S.; Okumra, K.; et al. Antimicrobial peptides human P-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur. J. Immunol. 2007, 37, 434-444.
35. Gerashchenko, O.L.; Zhuravel, E.V.; Skachkova, O.V.; Khranovska, N.N.; Filonenko, V.V.; Pogrebnoy, P.V.; Soldatkina, M.A. Biologic activities of recombinant human-beta-defensin-4 toward cultured human cancer cells. Exp. Oncol. 2013, 35, 76-82.
36. Lay, F.T.; Anderson, M.A. Defensins-components of the innate immune system in plants. Curr. Protein Pept. Sci. 2005, 6, 85-101.
37. Thomma, B.P.; Cammue, B.P.; Thevissen, K. Plant defensins. Planta 2002, 216, 193-202.
38. Stotz, H.U.; Thomson, J.G.; Wang, Y. Plant defensins: Defense, development and application. Plant Signal. Behav. 2009, 4, 1010-1012.
39. Ravi, C.; Jeyashree, A.; Devi, K.R. Antimicrobial peptides from insects: An overview. Res. Biotechnol. 2011, 2, 1-7.
40. Zanetti, M. The role of cathelicidins in the innate host defenses of mammals. Curr. Issues Mol. Biol. 2005, 7, 179-196.
41. Dürr, U.H.; Sudheendra, U.S.; Ramamoorthy, A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta 2006, 1758, 1408-1425.
42. Parisien, A.; Allain, B.; Zhang, J.; Mandeville, R.; Lan, C.Q. Novel alternatives to antibiotics: Bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J. Appl. Microbiol. 2008, 104, 1-13.
43. Heilborn, J.D.; Nilsson, M.F.; Kratz, G.; Weber, G.; Sorensen, O.; Borregaard, N.; Stähle-Bäckdahl, M. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Investig. Dermatol. 2003, 120, 379-389.
44. Ratcliffe, N.; Azambuja, P.; Mello, C.B. Recent advances in developing insect natural products as potential modern day medicines. Evid. Based Complement. Altern. Med. 2014, 2014, doi:10.1155/2014/904958.
45. Thevissen, K.; Ghazi, A.; de Samblanx, G.W.; Brownlee, C.; Osborn, R.W.; Broekaert, W.F. Fungal membrane responses induced by plant defensins and thionins. J. Biol. Chem. 1996, 271, 15018-15025.
46. Florack, D.E.A.; Stiekema, W.J. Thionins: Properties, possible biological roles and mechanisms of action. Plant Mol. Biol. 1994, 26, 25-37.
47. Li, S.S.; Gullbo, J.; Lindholm, P.; Larsson, R.; Thunberg, E.; Samuelsson, G.; Bohlin, L.; Claeson, P. Ligatoxin B, a new cytotoxic protein with a novel helix-turn-helix DNA-binding domain from the mistletoe Phoradendronliga. Biochem. J. 2002, 366, 405-413.
48. Otvos, L. Antibacterial peptides isolated from insects. J. Pept. Sci. 2000, 6, 497-511.
49. Dimarcq, J.L.; Bulet, P.; Hebru, C.H.; Hoffmann, J. Cysteine-rich antimicrobial peptides in invertebrates. Biopolymers 1998, 47, 465-477.
50. Pollock, J.J.; Denpitiya, L.; Mackay, B.J.; Iacono, V.J. Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect. Immun. 1984, 40, 702-707.
51. Tsai, H.; Bobek, L.A. Human salivary histatins: Promising anti-fungal therapeutic agents. Crit. Rev. Oral Biol. Med. 1998, 9, 480-497.
52. Park, C.B.; Kim, M.S.; Kim, S.C. A novel antimicrobial peptide from Bufobufogargarizans. Biochem. Biophys. Res. Commun. 1996, 218, 408-413.
53. Park, C.B.; Kim, H.S.; Kim, S.C. Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 1998, 244, 253-257.
54. Salzet, M. Vertebrate innate immunity resembles a mosaic of invertebrate immune responses. Trends Immunol. 2001, 22, 285-288.
55. Salzet, M.; Tasiemski, A. Involvement of pro-enkephalin-derived peptides in immunity. Dev. Comp. Immunol. 2001, 25, 177-185.
56. Bals, R. Epithelial antimicrobial peptides in host defence against infection. Respir. Res. 2000, 1, 141-150.
57. Fales-Williams, A.J.; Gallup, J.M.; Ramirez-Romero, R.; Brogden, K.A.; Ackerman, M.R. Increased anionic peptide distribution and intensity during progression and resolution of bacterial pneumonia. Clin. Diagn. Lab. Immunol. 2002, 9, 28-32.
58. Schittek, B.; Hipfel, R.; Sauer, B.; Bauer, J.; Kalbacher, H.; Stevanovic, S.; Schirle, M.; Schroeder, K.; Blin, N.; Meier, F.; et al. Dermcidin: A novel human antibiotic peptide secreted by sweat glands. Nat. Immunol. 2001, 2, 1133-1137.
59. Kolter, R.; Moreno, F. Genetics of ribosomally synthesized peptide antibiotics. Annu. Rev. Microbiol. 1992, 46, 141-163.
60. Oscâriz, J.C.; Pisabarro, A.G. Classification and mode of action of membrane-active bacteriocins produced by gram-positive bacteria. Int. Microbiol. 2001, 4, 13-19.
61. Pashkow, F.J. Oxidative stress and inflammation in heart disease: Do antioxidants have a role in treatment and/or prevention? Int. J. Inflam. 2011, 2011, 514-623.
62. Pham-Huy, L.A.; He, H.; Pham-Huy, C. Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci. 2008, 4, 89-96.
63. Yadav, U.; Ramana, K.V. Regulation of NF-/cB-induced inflammatory signaling by lipid peroxidation-derived aldehydes. Oxid. Med. Cell. Longev. 2013, 2013, 690-545.
64. Haslett, C. Granulocyte apoptosis and inflammatory disease. Br. Med. Bull. 1997, 53, 669-683.
65. Favaloro, B.; Allocati, N.; Graziano, V.; Di Ilio, C.; de Laurenzi, V. Role of apoptosis in disease. Aging 2012, 4, 330.
66. Nowsheen, S.; Yang, E.S. The intersection between DNA damage response and cell death pathways. Exp. Oncol. 2012, 34, 243-254.
67. Mader, J.S.; Salsman, J.; Conrad, D.M.; Hoskin, D.W. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol. Cancer Ther. 2005, 4, 612-624.
68. Jeong, S.Y.; Seol, D.W. The role of mitochondria in apoptosis. BMBRep. 2008, 41, 11-22.
69. Aerts, A.M.; Carmona-Gutierrez, D.; Lefevre, S.; Govaert, G.; François, I.E.; Madeo, F.; Santos, R.; Cammue, B.P.A.; Thevissen, K. The antifungal plant defensin RsAFP2 from radish induces apoptosis in a metacaspase independent way in Candida albicans. FEBSLett. 2009, 553, 2513-2516.
70. Lee, J.; Hwang, J.S.; Hwang, I.S.; Cho, J.; Lee, E.; Kim, Y.; Lee, D.G. Coprisin-induced antifungal effects in Candida albicans correlate with apoptotic mechanisms. Free Radic. Biol. Med. 2012, 52, 2302-2311.
71. Cerôn, J.M.; Contreras-Moreno, J.; Puertollano, E.; de Cienfuegos, G.A.; Puertollano, M.A.; de Pablo, M.A. The antimicrobial peptide cecropin A induces caspase-independent cell death in human promyelocyticleukemia cells. Peptides 2010, 31, 1494-1503.
72. Gallo, R.L.; Murakami, M.; Ohtake, T.; Zaiou, M. Biology and clinical relevance of naturally occurring antimicrobial peptides. J. Allergy Clin. Immunol. 2002, 110, 823-831.
73. Sattar, N. Inflammation and endothelial dysfunction: Intimate companions in the pathogenesis of vascular disease? Clin. Sci. 2004, 106, 443-446.
74. Edfeldt, K.; Agerberth, B.; Rottenberg, M.E.; Gudmundsson, G.H.; Wang, X.B.; Mandal, K.; Xu, Q.; Yan, Z.Q. Involvement of the antimicrobial peptide LL-37 in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1551-1557.
75. Ciornei, C.D.; Tapper, H.; Bjartell, A.; Sternby, N.H.; Bodelsson, M. Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: A laboratory study. BMC Cardiovasc. Disord. 2006, 6, 49.
76. Hoskin, D.W.; Ramamoorthy, A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta 2008, 1778, 357-375.
77. Renan, M.J. How many mutations are required for tumorigenesis? Implications from human cancer cells. Mol. Carcinog. 1993, 7, 139-146.
78. Suttmann, H.; Retz, M.; Paulsen, F.; Harder, J.; Zwergel, U.; Kamradt, J.; Wullich, B.; Unteregger, G.; Stöckle, M.; Lehmann, J. Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells. BMC Urol. 2008, 8, 5.
79. Ohsaki, Y.; Gazdar, A.F.; Chen, H.C.; Johnson, B.E. Antitumor activity of magainin analogues against human lung cancer cell lines. Cancer Res. 1992, 52, 3534-3538.
80. Baker, M.A.; Maloy, W.L.; Zasloff, M.; Jacob, L.S. Anticancer efficacy of Magainin2 and analogue peptides. Cancer Res. 1993, 53, 3052-3057.
81. Kusters, J.G.; van Vliet, A.H.M.; Kuipers, E.J. Pathogenesis of Helicobacter pylori Infection. Clin. Microbiol. Rev. 2006, 19, 449-490.
82. Ayala, G.; Escobedo-Hinojosa, W.I.; de la Cruz-Herrera, C.F.; Romero, I. Exploring alternative treatments for Helicobacter pylori infection. World J. Gastroenterol. 2014, 20, 1450.
83. Ilver, D.; Arnqvist, A.; Ogren, J.; Frick, I.M.; Kersulyte, D.; Incecik, E.T.; Berg, D.E.; Covacci, A.; Engstrand, L.; Borén, T. Helicobacter pylori adhesin binding fucosylatedhisto-blood group antigens revealed by retagging. Science 1998, 279, 373-377.
84. Mahdavi, J.; Sondén, B.; Hurtig, M.; Olfat, F.O.; Forsberg, L.; Roche, N.; Angstrom, J.; Larsson, T.; Teneberg, S.; Karlsson, K.A.; et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002, 297, 573-578.
85. Satin, B.; Del Giudice, G.; Della Bianca, V.; Dusi, S.; Laudanna, C.; Tonello, F.; Kelleher, D.; Rappuoli, R.; Montecucco, C.; Rossi, F. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med. 2000, 191, 1467-1476.
86. Amedei, A.; Cappon, A.; Codolo, G.; Cabrelle, A.; Polenghi, A.; Benagiano, M.; Tasca, E.; Azzurri, A.; D'Elios, M.M.; Del Prete, G.; et al. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J. Clin. Investig. 2006, 116, 1092-1101.
87. Polenghi, A.; Bossi, F.; Fischetti, F.; Durigutto, P.; Cabrelle, A.; Tamassia, N.; Cassatella, M.A.; Montecucco, C.; Tedesco, F.; de Bernard, M. The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo. J. Immunol. 2007, 178, 1312-1320.
88. Iwahori, A.; Hirota, Y.; Sampe, R.; Miyano, S.; Takahashi, N.; Sasatsu, M.; Kondo, I.; Numao, N. On the antibacterial activity of normal and reversed magainin 2 analogs against Helicobacter pylori. Biol. Pharm. Bull. 1997, 20, 805-808.
89. Numao, N.; Hirota, Y.; Iwahori, A.; Sasatsu, M.; Kondo, I.; Takao, K.I.; Kobayashi, S. Antibacterial activity of (+/-) 6-benzyl-1-(3-carboxypropyl) indane; a possible way to identify leading novel anti-H. pylori agents. Biol. Pharm. Bull. 1997, 20, 1204-1207.
90. Niehues, M.; Euler, M.; Georgi, G.; Mank, M.; Stahl, B.; Hensel, A. Peptides from Pisumsativum L. enzymatic protein digest with anti-adhesive activity against Helicobacter pylori: Structure-activity and inhibitory activity against BabA, SabA, HpaA and a fibronectin-binding adhesin. Mol. Nutr. Food Res. 2010, 54, 1851-1861.
91. Bajaj-Elliott, M.; Fedeli, P.; Smith, G.V.; Domizio, P.; Maher, L.; Ali, R.S.; Quinn A.G.; Farthing, M.J.G. Modulation of host antimicrobial peptide (ß-defensins 1 and 2) expression during gastritis. Gut 2002, 51, 356-361.
92. Rigano, M.M.; Romanelli, A.; Fulgione, A.; Nocerino, N.; D'Agostino, N.; Avitabile, C.; Frusciante, L.; Barone, A.; Capuano, F.; Capparelli, R. A novel synthetic peptide from a tomato defensin exhibits antibacterial activities against Helicobacter pylori. J. Pept. Sci. 2012, 18, 755-762.
93. Davis, P.B. Cystic fibrosis since 1938. Am. J. Respir. Crit. Care Med. 2006, 173, 475-482.
94. Welsh, M.J.; Ramsey, B.W.; Accurso, F.J.; Cutting, G.R. Cystic fibrosis. In The Metabolic and Molecular Bases of Inherited Disease, 8th ed.; Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., Eds.; McGraw-Hill: New York, NY, USA, 2001; pp. 5121-5128.
95. Dasenbrook, E.C.; Checkley, W.; Merlo, C.A.; Konstan, M.W.; Lechtzin, N.; Boyle, M.P. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 2010, 303, 2386-2392.
96. Pompilio, A.; Crocetta, V.; Scocchi, M.; Pomponio, S.; Di Vincenzo, V.; Mardirossian, M.; Gherardi, G.; Fiscarelli, E.; Dicuonzo, G.; Gennaro, R.; et al. Potential novel therapeutic strategies in cystic fibrosis: Antimicrobial and anti-biofilm activity of natural and designed a-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. BMC Microbiol. 2012, 12, 145.
97. Di Bonaventura, G.; Prosseda, G.; del Chierico, F.; Cannavacciuolo, S.; Cipriani, P.; Petrucca, A.; Superti, F.; Ammendolia, M.G.; Concato, C.; Fiscarelli, E.; et al. Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis. Int. J. Immunopathol. Pharmacol. 2007, 20, 529-537.
98. Hoffman, L.R.; D'Argenio, D.A.; MacCoss, M.J.; Zhang, Z.; Jones, R.A.; Miller, S.I. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005, 436, 1171-1175.
99. Linares, J.F.; Gustafsson, I.; Baquero, F.; Martinez, J.L. Antibiotics as intermicrobialsignaling agents instead of weapons. Proc. Natl. Acad. Sci. 2006, 103, 19484-19489.
100. Zhang, L.; Parente, J.; Harris, S.M.; Woods, D.E.; Hancock, R.E.; Falla, T.J. Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob. Agents Chemother. 2005, 49, 2921-2927.
101. Lawyer, C.; Pai, S.; Watabe, M.; Bakir, H.; Eagleton, L.; Watabe, K. Effects of synthetic form of tracheal antimicrobial peptide on respiratory pathogens. J. Antimicrob. Chemother. 1996, 37, 599-604.
102. Mittal, M.; Siddiqui, M.R.; Tran, K.; Reddy, S.P.; Malik, A.B. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 2014, 20, 1126-1167.
103. Haanen, C.; Vermes, I. Apoptosis and inflammation. Mediat. Inflamm. 1995, 4, 5-15.
104. Webster, K.A. Mitochondrial membrane permeabilization and cell death during myocardial infarction: Roles of calcium and reactive oxygen species. Future Cardiol. 2012, 8, 863-884.
105. Kam, P.C.A.; Ferch, N.I. Apoptosis: Mechanisms and clinical implications. Anaesthesia 2000, 55, 1081-1093.
106. Choi, K.Y.G.; Mookherjee, N. Multiple immune-modulatory functions of cathelicidin host defense peptides. Front. Immunol. 2012, 3, 149.
107. Schuerholz, T.; Brandenburg, K.; Marx, G. Antimicrobial peptides and their potential application in inflammation and sepsis. Crit. Care 2012, 16, 207.
108. Ramanathan, B.; Wu, H.; Ross, C.R.; Blecha, F. PR-39, a porcine antimicrobial peptide, inhibits apoptosis: Involvement of caspase-3. Dev. Comp. Immunol. 2004, 28, 163-169.
109. Pushpanathan, M.; Gunasekaran, P.; Rajendhran, J. Antimicrobial peptides: Versatile biological properties. Int. J. Pept. 2013, 2013, 675391.
110. Guilhelmelli, F.; Vilela, N.; Albuquerque, P.; Derengowski, L.D.S.; Silva-Pereira, I.; Kyaw, C.M. Antibiotic development challenges: The various mechanisms of action of antimicrobial peptides and of bacterial resistance. Front. Microbiol. 2013, 9, 353.
111. Cho, J.Y.; Choi, H.; Hwang, J.S. The novel biological action of antimicrobial peptides via apoptosis induction. J. Microbiol. Biotechnol. 2012, 22, 1457-1466.
112. Campbell, E.L.; Serhan, C.N.; Colgan, S.P. Antimicrobial aspects of inflammatory resolution in the mucosa: A role for proresolving mediators. J. Immun. 2011, 187, 3475-3481.
113. Semple, F.; Dorin, J.R. P-Defensins: Multifunctional modulators of infection, inflammation and more? J. Innate Immun. 2011, 4, 337-348.
114. Gordon, Y.J.; Romanowski, E.G.; McDermott, A.M. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res. 2005, 30, 505-515.
115. Nagaoka, I.; Niyonsaba, F.; Tsutsumi-Ishii, Y.; Tamura, H.; Hirata, M. Evaluation of the effect of human P-defensins on neutrophil apoptosis. Int. Immunol. 2008, 20, 543-553.